Firm intentionHealthcare18 October 2026

Merck KGaA, Darmstadt, Germany to acquire Silence Therapeutics plc

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

Deal facts

Buyer
Merck KGaA, Darmstadt, Germany
Target
Silence Therapeutics plc
Deal value
Not disclosed
Announced
18 October 2026
Status
Firm intention
Sector
Healthcare
Country
United Kingdom
Consideration
cash
What we know

Merck KGaA, based in Darmstadt, Germany, has agreed to acquire Silence Therapeutics plc in a cash deal that will take the healthcare company private. The transaction, announced on 18 October 2026, involves the German pharmaceutical group purchasing the British biotechnology firm. While the specific financial terms and total offer value have not been publicly reported, the consideration is structured entirely in cash. This move represents a significant shift for Silence Therapeutics, which will transition from a publicly listed entity to a privately held company under the ownership of Merck. The deal highlights the continued interest of major pharmaceutical players in acquiring assets within the healthcare sector, specifically focusing on companies with established research portfolios. By removing the target from public markets, the buyer aims to integrate the business without the pressures of quarterly reporting. The acquisition underscores the strategic importance of Silence Therapeutics within the broader industry landscape. As the process moves forward, the transaction remains at the firm intention stage. The completion of the deal is subject to necessary regulatory approvals and other customary closing conditions.

Deal timeline

1 update
  1. Firm intention

    Merck KGaA, Darmstadt, Germany firm intention to acquire Silence Therapeutics plc

    Item 1.01 Entry into a Material Definitive Agreement. Transaction Agreement On October 18, 2026, Silence Therapeutics plc, a public limited company incorporated in England and Wales (the “ Company ”), entered into a transaction agreement (the “ Transaction Agreement ”) with Merck KGaA, Darmstadt, Germany, a German corporation with general partners (“ Purchaser ”). The Transaction Agreement provide

    Source

For business owners

What would selling your own business involve?

Use the deal as a starting point, not a valuation benchmark. Learn the decisions behind a sale and apply them to your own preparation.

Guides are free to read. Free tools require email access; indicative results are not professional advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

Similar deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

Buyer history

Merck KGaA, Darmstadt, Germany

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive